108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
远程缺血预处理对抗抑郁药反应不足的抑郁症的疗效和安全性：一项随机对照试验
Authors Wang J, Shuai Y , Ren M, Li N, Li X, Li W, Jiang B, Wang L, Huang L , Ji X, Wang Z
Received 2 June 2025
Accepted for publication 18 September 2025
Published 8 October 2025 Volume 2025:21 Pages 2279—2291
DOI https://doi.org/10.2147/NDT.S536528
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Yu-Ping Ning
Jun Wang,1,* Yu Shuai,1,* Ming Ren,2,* Ningning Li,3 Xujuan Li,4 Wenfei Li,5 Binxun Jiang,4 Linlin Wang,4 Leping Huang,3 Xunming Ji,6,7 Zuowei Wang3,8
1Division of Mood Disorders, Shanghai Yangpu Mental Health Center, Shanghai, 200093, People’s Republic of China; 2Department of Neurology, Shanghai Blue Cross Brain Hospital, Tongji University, Shanghai, 200086, People’s Republic of China; 3Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, 200083, People’s Republic of China; 4Division of Mood Disorders, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310022, People’s Republic of China; 5Division of Mood Disorders, Anhui Mental Health Center, Hefei. Anhui, 230022, People’s Republic of China; 6Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 7Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 8Clinical Research Center for Mental Health, School of Medicine, Shanghai University, Shanghai, 200083, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zuowei Wang, Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, 200083, People’s Republic of China, Email wzwhk@163.com Xunming Ji, Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China, Email jixm@ccmu.edu.cn
Background: Physical therapies are recommended for individuals who are insufficiently responsive to pharmacotherapy and psychotherapy. But most physical therapy needs to be done in a hospital, so finding a physical therapy that can be done at home is very meaningful. This study intends to explore the efficacy and safety of remote ischemic preconditioning (RIPC) as an add-on therapy for depression.
Methods: A total of 60 major depressive disorder patients with inadequate response to escitalopram in this study were randomly assigned to sham or active RIPC group. The clinical symptoms, side-effects and physical examination were evaluated and recorded once every 2 weeks until the end of 8th week. The clinical symptoms were evaluated using the 16-item Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-16-SR) and the Generalized Anxiety Disorder 7-item scale (GAD-7). Side-effects included skin ecchymosis, risk of manic episodes, and RIPC-related serious adverse events. Physical examination included heart rate and blood pressure.
Results: No significant difference in QIDS-16-SR and GAD-7 scores between the two groups was found at baseline, week 2, week 4, week 6 and week 8 (P > 0.05). There were no significant differences in heart rate and blood pressure (including systolic and diastolic blood pressure) at any time point between the active group and the sham group (P > 0.05). There were no manic or hypomanic episodes associated with the study.
Conclusion: For depression patients with poor response to antidepressant therapy, the efficacy of RIPC as adjuvant therapy was not observed in this study. In general, RIPC adjuvant therapy is relatively safe, and has no significant effect on cardiovascular system, nor does it increase the risk of manic episode.
Keywords: depression patient, efficacy, physical therapy, remote ischemic, safety
1Division of Mood Disorders, Shanghai Yangpu Mental Health Center, Shanghai, 200093, People’s Republic of China; 2Department of Neurology, Shanghai Blue Cross Brain Hospital, Tongji University, Shanghai, 200086, People’s Republic of China; 3Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, 200083, People’s Republic of China; 4Division of Mood Disorders, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310022, People’s Republic of China; 5Division of Mood Disorders, Anhui Mental Health Center, Hefei. Anhui, 230022, People’s Republic of China; 6Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 7Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China; 8Clinical Research Center for Mental Health, School of Medicine, Shanghai University, Shanghai, 200083, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zuowei Wang, Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, 200083, People’s Republic of China, Email wzwhk@163.com Xunming Ji, Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, People’s Republic of China, Email jixm@ccmu.edu.cn
Background: Physical therapies are recommended for individuals who are insufficiently responsive to pharmacotherapy and psychotherapy. But most physical therapy needs to be done in a hospital, so finding a physical therapy that can be done at home is very meaningful. This study intends to explore the efficacy and safety of remote ischemic preconditioning (RIPC) as an add-on therapy for depression.
Methods: A total of 60 major depressive disorder patients with inadequate response to escitalopram in this study were randomly assigned to sham or active RIPC group. The clinical symptoms, side-effects and physical examination were evaluated and recorded once every 2 weeks until the end of 8th week. The clinical symptoms were evaluated using the 16-item Quick Inventory of Depressive Symptomatology (Self-Report) (QIDS-16-SR) and the Generalized Anxiety Disorder 7-item scale (GAD-7). Side-effects included skin ecchymosis, risk of manic episodes, and RIPC-related serious adverse events. Physical examination included heart rate and blood pressure.
Results: No significant difference in QIDS-16-SR and GAD-7 scores between the two groups was found at baseline, week 2, week 4, week 6 and week 8 (P > 0.05). There were no significant differences in heart rate and blood pressure (including systolic and diastolic blood pressure) at any time point between the active group and the sham group (P > 0.05). There were no manic or hypomanic episodes associated with the study.
Conclusion: For depression patients with poor response to antidepressant therapy, the efficacy of RIPC as adjuvant therapy was not observed in this study. In general, RIPC adjuvant therapy is relatively safe, and has no significant effect on cardiovascular system, nor does it increase the risk of manic episode.
Keywords: depression patient, efficacy, physical therapy, remote ischemic, safety